Table 1 General characteristic of patients

From: The Therapeuatic Effect of Endostar on Soft Carotid Plaque Neovascularization in Patients with Non-small Cell Lung Cancer

  

Before treatment

After treatment

N

T value

P value

EF (%)

Control

63.5 ± 5.8

64.1 ± 7.8

34

0.360

0.720

 

NP

63.7 ± 7.2

65.3 ± 5.2

48

2.028

0.445

 

ENP

64.3 ± 8.6

63.4 ± 6.8

43

0.538

0.592

SBP (mmHg)

Control

120.4 ± 13.3

122.1 ± 11.7

34

0.889

0.377

 

NP

117.6 ± 11.5

119.4 ± 14.4

48

1.053

0.295

 

ENP

118.9 ± 9.1

121.8 ± 16.2

43

1.023

0.309

DBP (mmHg)

Control

76.7 ± 8.6

73.5 ± 6.4

34

1.741

0.086

 

NP

74.9 ± 6.3

76.3 ± 7.1

48

1.022

0.310

 

ENP

75.2 ± 7.8

77.1 ± 5.2

43

1.329

0.187

TG (mmol/L)

Control

1.39 ± 0.44

1.38 ± 0.62

34

0.077

0.939

 

NP

1.32 ± 0.53

1.35 ± 0.47

48

0.293

0.770

 

ENP

1.41 ± 0.51

1.39 ± 0.43

43

0.197

0.845

HDL (mmol/L)

Control

2.52 ± 0.48

2.54 ± 0.62

34

0.149

0.882

 

NP

2.43 ± 0.42

2.47 ± 0.65

48

0.358

0.721

 

ENP

2.47 ± 0.51

2.39 ± 0.44

43

0.779

0.438

LDL (mmol/L)

Control

1.24 ± 0.51

1.28 ± 0.48

34

0.3330

0.740

 

NP

1.19 ± 0.63

1.23 ± 0.52

48

0.339

0.735

 

ENP

1.21 ± 0.57

1.23 ± 0.43

43

0.184

0.855

  1. Note: Data are the mean ± standard deviation. NP = Vinorelbine + Cisplatin; ENP = Endostar + Vinorelbine + Cisplatin; EF = Ejection fraction; SBP = Systolic blood pressure; DBP = Diastolic blood pressure; TC = Total cholesterol; TG = Total triglyceride; LDL = Low-density lipoprotein; HDL = High-density lipoprotein.
  2. There were no significant differences in EF, blood pressure, serum lipids among the three groups at recruitment (P > 0.05 for all). There were no significant changes in any group in, EF, blood pressure and blood lipid levels at recruitment and 1 month after treatment (P > 0.05 for all).
Back to article page